PATENT CLAIM ANALYSIS

Application Number: 16155841
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "224200"]

Abstract:
Heterocyclic compounds as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

Claim (Index 59):
The method of  claim 58 , wherein the inhibitor binds to Wee1 with an IC 50  of less than 1 \u03bcM according to a kinase assay.

Metadata:
- Claim Count in Document: 61.0
- Percentile: 97.0
- Lexical Diversity: 1.26087
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13406937', '13547314', '13655164', '14307680', '14748990']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8081181324763588
- 35 USC 102 Novelty (BERT): 0.5302661504316528
- Combined Prediction Score: 0.7803329342718882
- Mean Citation Score: 312.78887999999995
- Max Citation Score: 325.19232
- Similarity Product: 186.5992580941773

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test